RE: Medical QDs20 May 2026 21:18
Tbow, the article describes a different application (medical imaging), which isn't Nanoco's current focus (sensing/display). Interestingly, Nanoco did significant work in this area a few years ago (e.g., the VIVODOTS™ programme with UCL for image‑guided cancer surgery). While they closed that dedicated unit, the fundamental research and expertise remain within the company.
The key point is manufacturing. Nanoco's core patent (US7,588,828) covers:
· A method specifically designed for scale‑up to mass production
· The use of periodic table "groups" (e.g., Group 13 & 15), covering a wide range of materials, not just indium
· Doping with other elements – exactly what the medical imaging dots require (lanthanide doping)
So, while the article isn't directly about Nanoco, the scalable production method – including the ability to dope – is precisely what their patents protect. They have the platform technology and and license their IP if medical imaging with quantum dots ever gets beyond small lab scale synthesis.